Literature DB >> 23233542

Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation.

David G Cotter1, Rebecca C Schugar, Anna E Wentz, D André d'Avignon, Peter A Crawford.   

Abstract

During states of low carbohydrate intake, mammalian ketone body metabolism transfers energy substrates originally derived from fatty acyl chains within the liver to extrahepatic organs. We previously demonstrated that the mitochondrial enzyme coenzyme A (CoA) transferase [succinyl-CoA:3-oxoacid CoA transferase (SCOT), encoded by nuclear Oxct1] is required for oxidation of ketone bodies and that germline SCOT-knockout (KO) mice die within 48 h of birth because of hyperketonemic hypoglycemia. Here, we use novel transgenic and tissue-specific SCOT-KO mice to demonstrate that ketone bodies do not serve an obligate energetic role within highly ketolytic tissues during the ketogenic neonatal period or during starvation in the adult. Although transgene-mediated restoration of myocardial CoA transferase in germline SCOT-KO mice is insufficient to prevent lethal hyperketonemic hypoglycemia in the neonatal period, mice lacking CoA transferase selectively within neurons, cardiomyocytes, or skeletal myocytes are all viable as neonates. Like germline SCOT-KO neonatal mice, neonatal mice with neuronal CoA transferase deficiency exhibit increased cerebral glycolysis and glucose oxidation, and, while these neonatal mice exhibit modest hyperketonemia, they do not develop hypoglycemia. As adults, tissue-specific SCOT-KO mice tolerate starvation, exhibiting only modestly increased hyperketonemia. Finally, metabolic analysis of adult germline Oxct1(+/-) mice demonstrates that global diminution of ketone body oxidation yields hyperketonemia, but hypoglycemia emerges only during a protracted state of low carbohydrate intake. Together, these data suggest that, at the tissue level, ketone bodies are not a required energy substrate in the newborn period or during starvation, but rather that integrated ketone body metabolism mediates adaptation to ketogenic nutrient states.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23233542      PMCID: PMC3566508          DOI: 10.1152/ajpendo.00547.2012

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  72 in total

Review 1.  Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis.

Authors:  F G Hegardt
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

2.  A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting.

Authors:  Sarah E Hugo; Lourdes Cruz-Garcia; Santhosh Karanth; Ryan M Anderson; Didier Y R Stainier; Amnon Schlegel
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

3.  Obligate role for ketone body oxidation in neonatal metabolic homeostasis.

Authors:  David G Cotter; D André d'Avignon; Anna E Wentz; Mary L Weber; Peter A Crawford
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

4.  Genetic basis of mitochondrial HMG-CoA synthase deficiency.

Authors:  R Aledo; J Zschocke; J Pié; C Mir; S Fiesel; E Mayatepek; G F Hoffmann; N Casals; F G Hegardt
Journal:  Hum Genet       Date:  2001-07       Impact factor: 4.132

5.  Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet.

Authors:  Joel R Garbow; Jason M Doherty; Rebecca C Schugar; Sarah Travers; Mary L Weber; Anna E Wentz; Nkiruka Ezenwajiaku; David G Cotter; Elizabeth M Brunt; Peter A Crawford
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-31       Impact factor: 4.052

6.  A 6-bp deletion at the splice donor site of the first intron resulted in aberrant splicing using a cryptic splice site within exon 1 in a patient with succinyl-CoA: 3-Ketoacid CoA transferase (SCOT) deficiency.

Authors:  Toshiyuki Fukao; Satomi Sakurai; Marie-Odile Rolland; Marie-Therese Zabot; Andreas Schulze; Keitaro Yamada; Naomi Kondo
Journal:  Mol Genet Metab       Date:  2006-06-12       Impact factor: 4.797

7.  D-beta-hydroxybutyrate is neuroprotective against hypoxia in serum-free hippocampal primary cultures.

Authors:  R Masuda; J W Monahan; Y Kashiwaya
Journal:  J Neurosci Res       Date:  2005-05-15       Impact factor: 4.164

8.  Succinyl-CoA: 3-ketoacid CoA-transferase deficiency. A cause for ketoacidosis in infancy.

Authors:  J T Tildon; M Cornblath
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

9.  Substrate selection in the isolated working rat heart: effects of reperfusion, afterload, and concentration.

Authors:  F M Jeffrey; V Diczku; A D Sherry; C R Malloy
Journal:  Basic Res Cardiol       Date:  1995 Sep-Oct       Impact factor: 17.165

10.  Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture.

Authors:  J Edmond; R A Robbins; J D Bergstrom; R A Cole; J de Vellis
Journal:  J Neurosci Res       Date:  1987       Impact factor: 4.164

View more
  22 in total

1.  Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia.

Authors:  David G Cotter; Baris Ercal; Xiaojing Huang; Jamison M Leid; D André d'Avignon; Mark J Graham; Dennis J Dietzen; Elizabeth M Brunt; Gary J Patti; Peter A Crawford
Journal:  J Clin Invest       Date:  2014-10-27       Impact factor: 14.808

2.  Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice.

Authors:  David G Cotter; Baris Ercal; D André d'Avignon; Dennis J Dietzen; Peter A Crawford
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-05-27       Impact factor: 4.310

3.  Heterozygous carriers of succinyl-CoA:3-oxoacid CoA transferase deficiency can develop severe ketoacidosis.

Authors:  Hideo Sasai; Yuka Aoyama; Hiroki Otsuka; Elsayed Abdelkreem; Yasuhiro Naiki; Mitsuru Kubota; Yuji Sekine; Masatsune Itoh; Mina Nakama; Hidenori Ohnishi; Ryoji Fujiki; Osamu Ohara; Toshiyuki Fukao
Journal:  J Inherit Metab Dis       Date:  2017-07-10       Impact factor: 4.982

4.  Hepatocyte-Macrophage Acetoacetate Shuttle Protects against Tissue Fibrosis.

Authors:  Patrycja Puchalska; Shannon E Martin; Xiaojing Huang; Justin E Lengfeld; Bence Daniel; Mark J Graham; Xianlin Han; Laszlo Nagy; Gary J Patti; Peter A Crawford
Journal:  Cell Metab       Date:  2018-11-15       Impact factor: 27.287

Review 5.  Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.

Authors:  Patrycja Puchalska; Peter A Crawford
Journal:  Cell Metab       Date:  2017-02-07       Impact factor: 27.287

6.  Fasting induces a highly resilient deep quiescent state in muscle stem cells via ketone body signaling.

Authors:  Daniel I Benjamin; Pieter Both; Joel S Benjamin; Christopher W Nutter; Jenna H Tan; Jengmin Kang; Leo A Machado; Julian D D Klein; Antoine de Morree; Soochi Kim; Ling Liu; Hunter Dulay; Ludovica Feraboli; Sharon M Louie; Daniel K Nomura; Thomas A Rando
Journal:  Cell Metab       Date:  2022-05-17       Impact factor: 31.373

7.  Impact of peripheral ketolytic deficiency on hepatic ketogenesis and gluconeogenesis during the transition to birth.

Authors:  David G Cotter; Baris Ercal; D André d'Avignon; Dennis J Dietzen; Peter A Crawford
Journal:  J Biol Chem       Date:  2013-05-20       Impact factor: 5.157

Review 8.  Ketone body metabolism and cardiovascular disease.

Authors:  David G Cotter; Rebecca C Schugar; Peter A Crawford
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-08       Impact factor: 4.733

Review 9.  Ketone body metabolism and its defects.

Authors:  Toshiyuki Fukao; Grant Mitchell; Jörn Oliver Sass; Tomohiro Hori; Kenji Orii; Yuka Aoyama
Journal:  J Inherit Metab Dis       Date:  2014-04-08       Impact factor: 4.982

Review 10.  Lysosomes Mediate Benefits of Intermittent Fasting in Cardiometabolic Disease: The Janitor Is the Undercover Boss.

Authors:  Kartik Mani; Ali Javaheri; Abhinav Diwan
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.